lecture 2 Flashcards

1
Q

how are compounds in development named

A

the company developing them gives them a name and a number code

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how are compounds that show promise as a therapeutic drug named

A

they are names referring to the disease theyre effective against

saquinavir + ritonavir for antiviral drugs (hiv)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are marked medicines

A

medicine with a proprietry (owned by someone)

they have a name that only the owner company can use

nurofen, calpol etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is a proprietry name

A

a name given by the company that owns the medicine

the name is specific to the drug formulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is generic medicine

A

a drug that isnt covered by a patent application

many companies can sell, formulate and make profit from it (paracetamol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

similarity between generic medicine vs marketed medicine

A

same active principle
diff trade name

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

european law on generic drugs

A

generic medicines must have a international, non-proprietary name (rINN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

rINN

A

international
non proprietry name

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the european, international non proprietary name

A

usually the name of the drug

paracetamol, ibuprofen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

british approved names had to be changed to what

A

the international
non proprietry
names

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is a drug class

A

medicine with:

similar chemical structures

same mechanism of action (binds to the same target)

used to treat similar diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is a drug class defined by

A

a prototype drug

usually the first developed drug in that class

used as a reference to allow comparison

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the ATC

A

anatomical
therapeutic
chemical
classification
system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how does ATC classify drugs

A

classifies the active ingredient based on the organ or system that its therapeutic, pharmacological or chemical properties act upon

aka what does this drug affect!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the purpose of classifying drugs under ATC

A

allows us to monitor its use for research + improve quality medication use

eg: oh wow this is classified under cardiovascular system so it is probably mostly used for the heart<3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how many levels of ATC are there

A

5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what is the first level of ATC system

A

anatomical group it effects

1letter (a,b,c,d)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

2nd level of ATC system

A

therapeutic subgroup

2 digits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is therapeutics

A

treatment + healing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what is pharmacological

A

uses + effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

third level of ATC system

A

indicated the therapeutic/pharmacological subgroup

1 letter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

forth level of ATC system

A

chemical/therapeutic/pharmacological subgroup

1 letter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

5th level of ATC system

A

chemical substance

2 digits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

drug definition

A

raw material from animal/vegetable origin that contains active principles that alterates the normal functioning of the CNS when introduced to the b ody via any administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

drug || definition

A

a biologically active, chemically pure substance that has a therapeutic action.

  • reacts with biological environment + has the ability of curing, mitigating or preventing disease in humans/animals)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

mitigating meaning

A

reducing severity of something

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

medicine definition

A

drug in its proper dosage form, used in medication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

drug / medicine definition difference

A

drug: compound

medicine: tablet: its proper dosage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

drug target

A

biological entity (protein/gene) that interacts + has its activity modulated by a particular compound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

modulated meaning

A

controlling somethings influence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

druggable meaning

A

smt is druggable if its activity, behaviour or function, can be modulated by a therapeutic

therapeutic: small molecule/ biologics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

biological target example

A

nucleic acids
proteins

33
Q

7 stages from finding a drug to getting it on the market

A
  • early stage research + discovery
  • preclinical studies in animals
  • phase 1
  • phase 2
  • phase 3
  • fda review + approval
  • post approval
34
Q

what is phase 1 clinical development

A

focuses on safety
20-80 healthy ppts

1-2 years

35
Q

what is phase 2 of the clinical development

A

efficacy + safety

100-300 patients

1-2 years

36
Q

what is phase 3 clinical development

A

efficacy + safety
1,000-3,000 patients

2-3 years

37
Q

how long does approval from the fda last

A

1 - 2 years

38
Q

how many compounds are are lost during the process

A

from 5,000 - 10,000 (drug discovery + preclinical)

to 1 fda approved drug (fda review)

39
Q

how much does drug discovery cost + take

from the original idea to launching the finished product

A

1.5 billion dollars

12 - 15 years

40
Q

what must u do before identifying a target

A

find an unmet medical need

we must identify a disease in order to identify targets

41
Q

who is the concept of unmet medical need important to

A

stakeholders and regulators

42
Q

what is a stakeholder

A

rich companies that have interests in ‘x’

43
Q

what is a regulator

A

payers
academics
pharma industries
health technology assessment agencies (HTA)

44
Q

whats so important about unmet medical needs

A

theyre personal to everyone
everyones unmet need is different

should focus on all unmet needs as theyre all uncomforatble (not just unmet needs for critical or debilitating conditions)

45
Q

whats a debilitating condition

A

a condition that makes someone weak or infirm

46
Q

how and where do UMN occur

A
  • when current therapies that are available do not address a condition
  • when there are no approved molecules
  • when there are a few molecules in the late part of clinical studies (not out yet)
  • existing molecules are compromised by taking the effective dose of ‘x’.
47
Q

development of new medicine is driven by what ambition

A

treating unmet medical needs

the UMN drives ppl to want to meet these needs.

48
Q

list of therapeutic areas

A

-cancer
-cardiovascular diseases
-diabetes
-hiv , aids
- immune system diseases
- neurodegenerative diseases
- viral diseases

49
Q

what is a drug target

A

a biomolecule that is directly associated with the disease + is responsible for the cellular or molecular function

50
Q

drug target examples

A

enzymes // proteins
receptors
metabolic pathways / apoptosis
lipid membrane
ion channles
dna/rna

51
Q

what is the benefit of discovering a drug target

A

allows researchers to optimize the drug for a particular disease or condition

52
Q

optimise meaning

A

make it the best
identify its most effective use

53
Q

drug target characteristics

A
  • confirmed role in pathophysiology of a disease/ is disease modifying
  • expression is not evenly distributed throughout the body
  • its 3d structure is availabe to assess druggability
  • easily assayable/tested allowing screening
  • has a promising toxicity profile, adverse affects can be predicted using phenotypic data
  • favourable intellectual property status (IP) (relavent for big pharma as it shows how its marketed and sold)
54
Q

what is the modern drug discovery process

A

target identification
target charactisation
target validation

55
Q

initial hypothesis in drug discovery

A

that a particular molecule is the key or causes a pathogenic or symptomatic mechanism in a disease.

eg: hypothesising that this molecule causes the inflammation etccc.

56
Q

target identification in drug discovery

A

identifying the function of a possible therapeutic target (gene/protein) and its role in the disease

eg: identifying ‘x’ is the drug target bc iit causes the inflammation

57
Q

in drug discovery what is target identification followed by

A

target characterisation of the molecular mechanism addressed by the target

  • u found the target, now u need to see its mechanism for how it causes the inflammation
58
Q

target validation in drug discovery

A

shows that modulation of the target is likely to have a therapeutic effect

59
Q

modulation meaning

A

controlling its influence

60
Q

what is the goal in target identification

A

to find a biological target (protein//nucleic acid) whos activity can be regulated with a therapeutic

61
Q

target identification techniques

A

in silico
laboratory

62
Q

in silico target identification technique

A

silico screening
machine based methods
experimentation performed by a computer

63
Q

laboratory target identification technique

A

biological assays such as expression profiling of rna or proteins

aka measuring which genes from the genome are being expressed in particular cells at any given time

or functional screening: gene knockdown, knockout, overexpression

64
Q

what is gene knockdown

A

reducing the genes expression

65
Q

what is gene knockout

A

eliminating the gene

66
Q

what is gene overexpression

A

turning certain genes on

67
Q

what is target validation

A

ensuring that engagement of the target has potential therapeutic benefits

aka if we do smt to the target, will it lead to a positive effect.

68
Q

2 approaches to target validation

A

chemical + genetic approach

69
Q

chemical approach to target validation

A

involves the use of drugs to show that inhibition of the target results in disease inhibition

70
Q

genetic approach to target validation

A

target gene knockdown (reduced expression) - rna

target gene knockout (gene elimination) - gene

71
Q

target validations can be divided into what 2 groups

A

in vivo

in vitro lab tests

72
Q

in vivo division of target validation

A

use of disease models (animals)
use of animal alternatives: worms, microorganisms, computer models, 3d tissue cultures.

73
Q

in vitro division of target validation

A

lab tests
- cell/ tissue based experiments
- parameters are studied (ionic conc, enzyme activity, protein expression profiles)
-study of the targets biological function when bound to different ligands (diff drug candidates)

74
Q

what is a parameter

A

a measurable factor that defines a system

75
Q

stages of early stage research + discovery

A

target identification
hit generation
lead generation

76
Q

what is found in the hit generation

A

%wegotahit!

finding compounds that engage with the bio target + have good properties

77
Q

what is the lead generation in the early research and discovery stage of drug discovery

A

%theyretakingthelead

from the possible hits

analysis + improvement of compounds with pharmacological activity, the correct potency, solubility + stability

78
Q
A